Mattr’s New CM-P Includes Adverse Event monitoring

…we’ve done significant research and development to eliminate those barriers.

AUSTIN, Texas (PRWEB)
September 13, 2019

Today, Mattr, the leading technology enabled full service influencer marketing provider, announced Campaign Manager – Pharma (CM-P), the first influencer marketing solution designed specifically for the pharmaceutical industry.

Two pharmaceutical companies are already running campaigns using CM-P.

CM-P is the latest solution from Mattr developed specifically to address the marketing challenges facing highly regulated industries, such as pharmaceuticals.

Regulatory compliance has long made marketing difficult for companies selling pharmaceuticals. With such strict regulations in place, pharmaceutical companies struggle to adopt and incorporate the latest innovative marketing tactics. Influencer marketing is the latest example of this challenge.

Social media content published by pharmaceutical companies must go through onerous approval cycles prior to publishing, so many companies have hesitated to work with influencers, fearing they’d lose content oversight. Additionally, once content is published, community engagement on the content must be closely monitored. Certain comments could require Food & Drug Administration notification by the company. Failing to give that notification could result in penalties.

“We’ve actually had several pharmaceutical companies tell us that they didn’t think influencer marketing was an option for them until they found Mattr,” said Jack Holt, CEO and co-founder, Mattr.

CM-P, developed specifically for the pharmaceutical industry, solves the influencer marketing challenges facing pharmaceutical companies.

Adverse Effect Comment Moderation

The solution’s adverse effect comment moderation system automates community engagement monitoring and alerts, allowing pharmaceutical companies to easily abide by FDA regulations. If a comment is left on an influencer post that could warrant FDA notification, an alert is sent prompting the partnering pharmaceutical company to review the comment.

Additionally, the non-compete monitoring function can also be used by pharmaceutical companies to ensure influencers they work with don’t violate competitive restrictions included in the parameters of their relationship. Competitor handles and hashtags can be entered into the system to monitor usage, making it easier to quickly discover violations of influencer contracts.

Branded vs. Unbranded Campaigns

CM-P was developed to manage both types of campaigns pharmaceutical companies run: branded campaigns, which explicitly name a drug brand, and unbranded campaigns, which operate similar to a public service announcement and do not name a drug brand.

Content Review and Approval

CM-P features an easy to use environment for content review and approval. Since content faces such strict scrutiny prior to publishing, CM-P enables an influencer to upload content for approval from the pharmaceutical company prior to publishing or submission to its system for approval. This ensures that all content tied to the pharmaceutical brand is in compliance with federal regulations – and gives the company the opportunity to reject any content that may violate federal regulations.

“Based on what we’ve seen in our competitive research, Campaign Manager – Pharma is unique in that it’s uniquely developed with the tools and expertise needed for the pharmaceutical industry,” said Holt. “We put significant resources into gaining a deep understanding of the regulations they face. We wanted to make sure pharmaceutical companies would be very comfortable partnering with us since most have probably never done influencer marketing.”

CM-P also includes all the other benefits that Mattr’s core influencer marketing platform has provided to brands over the past six years:

• PersonaMesh Audience Matching – many influencer marketing platforms will align an influencer’s demographic and socioeconomic profile with the brand looking to work with them, but Mattr’s technology goes a step further, finding matches for the audience of influencers.
• Cost Per Engagement Model – this performance-based model ensures that brands are only paying for the results they receive from working with an influencer.
• Full Service Influencer Campaigns – Mattr offers the option of full service, white glove influencer activation and management, freeing brands from the time investment necessary to run influencer campaigns.

“Mattr is a company for highly regulated industries,” said Holt. “We’ve seen the barriers that prevent companies in industries like pharmaceuticals from running influencer campaigns. Over the past few years we’ve done significant research and development to eliminate those barriers. Campaign Manager – Pharma is the latest example of that. We’re very excited to be able to help pharmaceutical companies work with influencers to tell the stories of the medications they’re creating.”

About Mattr

MATTR, leaders in influencer campaigns for highly regulated industries, is the only full-service influencer marketing provider with detailed audience insights from PersonaMesh™. We go beyond demographics into psychographics such as values and interests so that your influencer campaigns align with your campaign targets.

Share article on social media or email:

With Handy Gym, anyone can achieve a total body workout that’s easier on the body than weightlifting, and it’s completely portable.

VIGO, Spain (PRWEB)
September 13, 2019

Using the same training methods developed by NASA for astronauts to use while in orbit, Handy Gym is the inertial training tool for everyday people to achieve sculpted, strong muscles without lifting weights. After raising more than $386,000 during its 40-day Kickstarter campaign, Handy Gym has moved into production and over to Indiegogo’s InDemand platform to continue taking pre-orders.

“Though I initially developed Handy Gym to provide fitness solutions for people for whom weightlifting was not an option, I quickly realized how many people would benefit from this tool,” said Manuel Montes, CEO of Micaton, creator of Handy Gym. “With Handy Gym, anyone can achieve a total body workout that’s easier on the body than weightlifting, and it’s completely portable.”

Handy Gym is perfect for a variety of fitness levels and exercises. By using a combination of handles and mounts, Handy Gym can be used to perform more than 200 exercises. Target specific muscle groups or achieve a full body workout with this one small piece of equipment.

To customize the resistance for muscle groups or fitness levels, Handy Gym uses a system of three interchangeable discs — yellow, blue or red — to achieve varying inertia levels. Yellow discs provide the least resistance, blue provide medium resistance, and red provide high resistance – up to 220lbs. The lower resistance discs are ideal for smaller muscle groups, like arms and shoulders or for those newer to fitness routines. Higher resistance discs are best suited for large muscle groups including legs and back or for those who are more advanced in their fitness regimen.

Allowing for fitness on the go sets Handy Gym apart from the rest. Weighing in at 28 ounces, it’s compact enough to fit inside a backpack or suitcase and assembles in seconds. With a complementary smartphone app, users can track their training and monitor improvements over time. Sensors within Handy Gym also convey real-time workout data including caloric burn. Handy Gym is available to pre-order starting at $510 by visiting the InDemand campaign page.

About Micaton

Micaton is a team of fitness enthusiasts and serial entrepreneurs who believe in creating smarter devices for smarter and more effective fitness and training experiences. This Spanish startup was born in 2018 with the aim of creating, developing and putting into value a new training solution that allows for exercising anywhere and at any time. Micaton uses the latest technology and apply the highest quality standards in its solutions. For more information, visit https://handygymfit.com/.

Share article on social media or email:

Abrams Eye Institute

“Having this opportunity is very exciting for me. I look forward to being able to perform more surgeries with this incredible technology to give patients more individualized options for their vision.” – Dr.Jack Abrams.

LAS VEGAS (PRWEB)
September 13, 2019

Abrams Eye Institute, an American Vision Partners affiliate, was the first practice in Nevada to provide a new solution for patients with presbyopia following the recent FDA approval of Alcon’s Acrysof IQ PanOptix Trifocal IOL.

Alcon has paired their Acrysof IQ Intraocular Lense (“IOL”) with a proprietary design from PanOptix. With this breakthrough technology, the new trifocal lens will allow cataract and refractive lens exchange surgeons to correct for their patients’ immediate, near and distance vision.

“We are proud to bring this new class of IOLs to the largest eye care market in the world,” said David J. Endicott, Chief Executive Officer of Alcon.

FDA approval was based on results from a study of 12 investigational sites in the U.S. “With this single trifocal lens design, PanOptix patients demonstrated exceptional, uninterrupted vision. The results also showed high patient satisfaction with more than ninety-nine percent of PanOptix patients saying they would choose the same lens again.”

Dr. Jack Abrams, MD, the Founder of Abrams Eye Institute, was the first eye surgeon in Nevada to perform surgery use the trifocal lens. The surgery took place on Wednesday, Sept 4. Dr. Abrams and the team at Abrams Eye Institute continue to be at the forefront of new technology in identifying the best vision solutions for their patients.

“We are extremely proud to have Dr. Abrams perform the first surgery in Nevada utilizing this incredible new lens. One of the fundamental tenets of our practice is providing our patients with the most advanced technology options for improving and preserving their vision,” said Kyle Bohannon, President & CEO of American Vision Partners.

“Having this opportunity is very exciting for me. I look forward to being able to perform more surgeries with this incredible technology to give patients more individualized options for their vision,” says Dr.Jack Abrams.

For more information about Abrams Eye Insitute and our expertise in Trifocal IOL implantation, visit http://www.AbramsEyeInstitute.com/

Visit https://www.alcon.com/media-release/alcon-introduces-acrysof-iq-panoptix-trifocal-iol-us-first-and-only-fda-approved to find out more about the Acrysof IQ PanOptix Trifocal IOL.

About American Vision Partners

American Vision Partners (“AVP”) is one of the nation’s largest and fastest growing eye care physician practice management organizations. AVP serves communities throughout Arizona, Nevada, and New Mexico with more than 120 nationally recognized doctors, 61 locations, including 22 ambulatory surgical centers, and 25 satellite clinics.

AVP partners with the most respected ophthalmology practices in the country, and integrates a best-in-class management system, infrastructure and technology to provide the highest-quality patient care. Our partner practices, including Retinal Consultants of Arizona, Barnet Dulaney Perkins Eye Center, Southwestern Eye Center, M&M Eye Institute, and Abrams Eye Institute, have on average been in practice for more than 35 years.

About Abrams Eye Institute

Founded in 2005 by Jack Abrams, M.D, Abrams Eye Institute provides the most advanced and comprehensive ophthalmologic services in Nevada. Abrams Eye Institute is Southern Nevada’s premier provider of ophthalmologic services, including LASIK surgery, cataract surgery and the treatment of all common eye disorders.

Share article on social media or email: